Cargando…

Rapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy

Alzheimer’s disease (AD) is a sporadic or familial neurodegenerative disease of insidious onset with progressive cognitive decline. Although numerous studies have been conducted or are underway on AD, there are still no effective drugs to reverse the pathological features and clinical manifestations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Si-Jia, Zhang, Sheng-Xiao, Li, Yang, Xu, Sui-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557994/ https://www.ncbi.nlm.nih.gov/pubmed/37810956 http://dx.doi.org/10.2147/CIA.S429440

Ejemplares similares

Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapy
por: Ma, Jian-Chao, et al.
Publicado: (2023)

The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
por: Talboom, Joshua S, et al.
Publicado: (2015)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
por: Zhang, Fen, et al.
Publicado: (2023)

Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
por: Quan, Meina, et al.
Publicado: (2023)

Evaluating the Effectiveness of GTM-1, Rapamycin, and Carbamazepine on Autophagy and Alzheimer Disease
por: Zhang, Lijuan, et al.
Publicado: (2017)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
por: Carroll, Trae, et al.
Publicado: (2021)

Translational Research in Alzheimer’s and Prion Diseases
por: Di Fede, Giuseppe, et al.
Publicado: (2018)

Metastatic perivascular epithelioid cell tumor responding to mammalian target of rapamycin inhibition
por: Ghosh, Indranil, et al.
Publicado: (2014)

ANTI-CELL SENESCENT EFFECTS OF RAPAMYCIN AND THEIR ROLE IN DISEASES, INCLUDING ALZHEIMER’S
por: Perez, Viviana I
Publicado: (2019)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
por: Wang, Tao, et al.
Publicado: (2023)

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
por: Abate, Giulia, et al.
Publicado: (2021)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Case report: Hypnic headache responds to agomelatine–a potential prophylactic treatment option
por: Xu, Sui-yi, et al.
Publicado: (2023)

Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
por: Chen, Yijun, et al.
Publicado: (2023)

Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone Mice
por: Oaks, Zachary, et al.
Publicado: (2016)

The airbag problem–a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer’s disease
por: Krstic, Dimitrije, et al.
Publicado: (2013)

Longevity, aging and rapamycin
por: Ehninger, Dan, et al.
Publicado: (2014)

MicroRNAs and the cellular response to rapamycin: Potential role in diagnosis and therapy
por: Totary-Jain, Hana, et al.
Publicado: (2013)

Characterizing Treatment Non-responders vs. Responders in Completed Alzheimer’s Disease Clinical Trials
por: Wang, Dulin, et al.
Publicado: (2023)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

The Potential Roles of Redox Enzymes in Alzheimer’s Disease: Focus on Thioredoxin
por: Jia, Jinjing, et al.
Publicado: (2021)

Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
por: Beck, J Thaddeus
Publicado: (2015)

Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
por: Wirths, Oliver, et al.
Publicado: (2020)

Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application
por: Enengl, Joachim, et al.
Publicado: (2020)

Are ketogenic diets promising for Alzheimer’s disease? A translational review
por: Lilamand, Matthieu, et al.
Publicado: (2020)

Translating the biology of aging into novel therapeutics for Alzheimer disease
por: Hara, Yuko, et al.
Publicado: (2019)

Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
por: Squitti, Rosanna, et al.
Publicado: (2020)

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
por: Arya, Ashwani, et al.
Publicado: (2021)

The Target of Rapamycin and Mechanisms of Cell Growth
por: Tee, Andrew R.
Publicado: (2018)

Stem cell therapy for Alzheimer's disease
por: Liu, Xin-Yu, et al.
Publicado: (2020)

New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
por: Carraway, Hetty, et al.
Publicado: (2004)

The Development of Pharmacological Therapies for Alzheimer’s Disease
por: Lin, Ping, et al.
Publicado: (2021)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
por: Shi, Yinan, et al.
Publicado: (2021)

An Emerging Role for the Mammalian Target of Rapamycin in “Pathological” Protein Translation: Relevance to Cocaine Addiction
por: Dayas, Christopher V., et al.
Publicado: (2012)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Nicotinamide as potential biomarker for Alzheimer’s disease: A translational study based on metabolomics
por: Dalmasso, María C., et al.
Publicado: (2023)

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
por: Zhao, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sd2ov994njn89huiaj03b1afgu